ASSESSING EMERGENCY ROOM NURSES’ AWARENESS OF NOVEL TREATMENTS AND EMERGING INNOVATIONS IN ANAPHYLAXIS MANAGEMENT
DOI:
https://doi.org/10.71000/bx844691Keywords:
Anaphylaxis, Epinephrine, Evidence-Based Practice, Emergency Nursing, Patient Safety, Therapeutics, Treatment OutcomeAbstract
Background: Anaphylaxis is an acute, potentially fatal systemic hypersensitivity reaction that requires rapid recognition and immediate treatment to prevent severe morbidity or mortality. Emergency room nurses play a pivotal role in early identification and timely management; however, international evidence suggests persistent gaps in knowledge regarding diagnostic criteria, epinephrine administration, and post-treatment monitoring. Inadequate awareness of updated guidelines and emerging therapeutic options may compromise patient safety, particularly in high-pressure emergency settings.
Objective: To assess the level of awareness and knowledge among emergency room nurses regarding updated definitions, evidence-based management protocols, and novel treatments for anaphylaxis, and to evaluate how this awareness may influence clinical practice.
Methods: A descriptive cross-sectional study was conducted among 60 emergency room nurses working in tertiary care hospitals of Bahawalpur. Participants were recruited using non-probability convenience sampling. Data were collected through a structured, self-administered, closed-ended questionnaire designed to assess demographic characteristics, clinical exposure, knowledge of anaphylaxis recognition, epinephrine use, complications, and awareness of emerging therapies. Data were analyzed using SPSS version 27, applying descriptive statistics including frequencies and percentages.
Results: Among the participants, 66.7% correctly identified anaphylaxis as a life-threatening condition, while 33.3% demonstrated incorrect or uncertain understanding. Epinephrine was recognized as the first-line treatment by 58.3% of nurses; however, only 31.7% correctly identified the recommended intramuscular dose and route. A substantial proportion (85.0%) incorrectly believed that a single dose of epinephrine is always sufficient. Awareness of biphasic anaphylaxis was limited, with only 18.3% identifying it as a serious delayed complication. Knowledge of novel treatment approaches was moderate, and 70.0% expressed interest in further training, despite reported limitations in access to updated therapies and educational resources.
Conclusion: Emergency room nurses demonstrated moderate overall awareness of anaphylaxis management, but critical deficiencies were evident in epinephrine dosing, recognition of delayed complications, and familiarity with emerging therapies. Strengthening continuous professional education and improving access to updated, evidence-based guidelines are essential to enhance emergency care quality and patient safety.
References
Alanazy, A., Boodai, R. S., Alhulaybi, B. I., Alraihan, A. I., Almulhim, R. A., Almulhim, B. F., Rajappan, S. K., Alruwaili, A., & Alanazi, A. (2024). Awareness of anaphylaxis among public in Al-Ahsa City of Saudi Arabia: A cross-sectional study. PloS one, 19(12), e0315722.
Alsaleem, H. N., Almuzaini, A. S., Aldakheel, F. N., Almuhaisni, R., Alsharekh, N. A., Alharkan, M. K., Aldakhil, L. N., s Aljudayi, A., Alkhalifah, K. A., & Altuwaiyan, A. F. (2024). Knowledge and Preparedness of Physicians in Relation to Anaphylaxis at Primary Healthcare Centers in Al-Qassim, Saudi Arabia. Cureus, 16(3).
Arga, M., Topal, E., Yılmaz, S., Erdemli, P. C., Bıçakcı, K., & Bakırtaş, A. (2021). Healthcare workersknowledge level regarding anaphylaxis and usage of epinephrine auto-injectors. The Turkish journal of pediatrics, 63(3), 372-383.
Cimen, S. S., & Sayili, S. B. (2022). Level of knowledge among healthcare professionals regarding anaphylaxis. Asia Pacific Allergy, 12(4), e41.
Dharmaratne, C., & Dahanayaka, N. (2023). Knowledge on anaphylaxis, its associated factors and self-perceived confidence on its management among medical officers attached to the Teaching Hospital Karapitiya. Galle Medical Journal, 28(3).
El-Sayed, Z. A., El-Owaidy, R., Hussein, S. M., Hossam, D., El-Sawi, I. H., Adel, A., Almalky, M., Elshebiny, E., Ismaeel, A. Y., & Osman, N. S. (2021). Physicians' knowledge and practice concerning diagnosis and management of anaphylaxis: The situation in Egypt. African Journal of Emergency Medicine, 11(4), 464-470.
González-Díaz, S. N., Villarreal-González, R. V., Fuentes-Lara, E. I., del Rocío Salinas-Díaz, M., de Lira-Quezada, C. E., Macouzet-Sánchez, C., Macías-Weinmann, A., Guzmán-Avilán, R. I., & García-Campa, M. (2021). Knowledge of healthcare providers in the management of anaphylaxis. World Allergy Organization Journal, 14(11), 100599.
Noh, Y., & Lee, I. (2021). A mixed-methods approach-based study of anaphylaxis awareness and educational needs among nursing students. International Journal of Environmental Research and Public Health, 18(17), 9280.
Phan, D., Nguyen, T., Do, H., & Dau, T. (2024). Assessing Knowledge of Vietnamese Nurses about Prevention and Treatment of Anaphylaxis: A Cross-Sectional Study. International Journal of Public Health Asia Pacific, 105-116.
Casale TB, Wang J, Oppenheimer J, Nowak-Wegrzyn A. Acute At-Home Management of Anaphylaxis: 911: What Is the Emergency? J Allergy Clin Immunol Pract. 2022;10(9):2274-9.
Motosue MS, Li JT, Campbell RL. Anaphylaxis: Epidemiology and Differential Diagnosis. Immunol Allergy Clin North Am. 2022;42(1):13-25.
Gorham NP. Anaphylaxis:: After the Emergency Department. Emerg Med Clin North Am. 2022;40(1):33-7.
Shaker M, Abrams EM, Sublett JW. Contextual community epinephrine prescribing: Is more always better? Ann Allergy Asthma Immunol. 2023;131(2):176-84.
Acquisto NM, Bodkin RP, Vabishchevich Y, Falkowski MW, Tuttle SC, Jones CM, et al. Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department. Allergy Asthma Proc. 2023;44(4):283-90.
Krajewski GS, Krajewski T. Evaluation and Management of Food Allergies in the Emergency Department. Immunol Allergy Clin North Am. 2023;43(3):491-501.
Gabrielli S, Clarke AE, Morris J, Gravel J, Lim R, Chan ES, et al. Fruit-Induced Anaphylaxis: Clinical Presentation and Management. J Allergy Clin Immunol Pract. 2021;9(7):2825-30.e2.
Wallace DV. Knowledge gaps in the diagnosis and management of anaphylaxis. Ann Allergy Asthma Immunol. 2023;131(2):151-69.
Zeke A, Sudhir A. Management of allergic reactions and anaphylaxis in the emergency department. Emerg Med Pract. 2022;24(7):1-24.
Hong B, Merrill KA, Golding MA, Simons E, Ben-Shoshan M, Protudjer JLP. Prehospital epinephrine administration for treating anaphylaxis among those with comorbid asthma: A scoping review. Ann Allergy Asthma Immunol. 2023;131(1):69-74.e1.
Lowing D, Chung S, Luk J, Dingeldein L. Prehospital Epinephrine Use in Pediatric Anaphylaxis by Emergency Medical Services. Pediatr Emerg Care. 2022;38(8):367-71.
Dribin TE, Sampson HA, Zhang Y, Boyd S, Zhang N, Michelson KA, et al. Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study. Lancet Child Adolesc Health. 2025;9(7):484-96.
Ducharme L, Gabrielli S, Clarke AE, Morris J, Gravel J, Lim R, et al. Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management. Ann Allergy Asthma Immunol. 2022;129(3):335-41.
Dribin TE, Waserman S, Turner PJ. Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes. J Allergy Clin Immunol Pract. 2023;11(4):1036-46.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Kehkashan Shabir, Husna Najeeb, Imtiaz Ramzan, Muhammad Danish, Rubina Haider, Muhammad Bilal Hussain, Farrukh Jamal (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.





